Pediatrics Doctors in Bowie, MD Accepting Medicare

9 Pediatrics doctors found. Showing 1 - 9

Dr. Amina T Watson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1700 Science Drive, Suite 102, Bowie, MD 20715 Phone: 240-556-1000

Dr. Toni Lynn Thompson-chittams, D.O Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4357 Northview Dr, Bowie, MD 20716 Phone: 301-352-6515    Fax: 301-352-6516

Dr. Valorie Anlage, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Drive, Suite 116, Bowie, MD 20715 Phone: 301-464-2300    Fax: 301-776-8052

Dr. Brenda Karen Pettus-bellamy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd, Suite 301, Bowie, MD 20715 Phone: 301-249-8838    Fax: 301-249-5334

Dr. Jeannine Avis Clark, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6915 Laurel Bowie Road, Suite 301, Bowie, MD 20715 Phone: 301-249-8838    Fax: 301-249-5334

Dr. Necole Elease Washington, M.D. Pediatrics - Hospice and Palliative Medicine Medicare: Not Enrolled in Medicare Practice Location: 2905 Mitchellville Rd, Suite 108, Bowie, MD 20716 Phone: 301-218-0398    Fax: 301-218-0040

Suzette Scipio - Ettienne, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2905 Mitchellville Rd, Ste 115, Bowie, MD 20716 Phone: 301-390-7960    Fax: 301-218-2800

Dr. Azar Dashti, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4379 Northview Dr, Bowie, MD 20716 Phone: 301-262-2627    Fax: 301-262-8411

Dr. Yvonne Marie Jackson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14300 Gallant Fox Ln, Suite 203, Bowie, MD 20715 Phone: 301-262-4784    Fax: 301-262-2767

News Archive

Naldemedine significantly improves opioid-induced constipation in patients with chronic non-cancer pain

Shionogi today announced pivotal phase III study (COMPOSE I) results showing that once-daily treatment with naldemedine significantly improved opioid-induced constipation (OIC) compared to placebo in patients with chronic non-cancer pain.

Protein p62 acts as molecular brake to keep inflammation in check, avoid collateral damage

Inflammation is a Catch-22: the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and sometimes leading to organ failure and death. Researchers at University of California, San Diego School of Medicine have discovered that a protein known as p62 acts as a molecular brake to keep inflammation in check and avoid collateral damage.

Synexus continues to grow in 2010 and beyond

During the first quarter of 2010 Synexus has seen growth in Germany reach thirty per cent as international sponsors take advantage of the additional patient reach the company can now offer following its acquisition of eight sites there as part of its takeover of Leipzig-based Clinpharm at the end of 2009.

AstraZeneca signs definitive agreement to acquire Novexel

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing.

Read more Medical News

› Verified 4 days ago